Page last updated: 2024-10-31

midodrine and Intestinal Obstruction

midodrine has been researched along with Intestinal Obstruction in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Intestinal Obstruction: Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pathak, A1
Debats, P1
Galinier, M1
Montastruc, JL1
Senard, JM1

Other Studies

1 other study available for midodrine and Intestinal Obstruction

ArticleYear
Intestinal obstruction associated with oral midodrine.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2004, Volume: 14, Issue:3

    Topics: Adrenergic alpha-Agonists; Female; Gastrointestinal Motility; Humans; Intestinal Obstruction; Middle

2004